Sequent Scientific

PE is negative at -42

THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED

Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane

Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years

Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition

mutual funds have increased stake from 0.25% to 1%

DII also increasing stake significantly

stock has come out of accumulation Phase!!!
bankniftyviewChart PatternsTechnical IndicatorsniftyintradaytradesetupniftypredictionniftytrendniftyviewPHARMApharmaceuticalspharmastockssequentscientificTrend Analysis

更多:

免責聲明